🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Elizabeth A. V. Jones

Maastricht University

ORCID: 0000-0002-2006-7064

Also affiliated with VIB-KU Leuven Center for Cancer Biology, KU Leuven

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease”.

Prospective Analysis of Mesotheliomas in Subjects With BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.132

N/A

0.374DataRank · unranked

5 citations

F. Gonzalez Hernandez, Haitao Wang, Ruihong Wang, Stephanie Shiffka, Niharika Shah +26 more

Spatial Mechano‐Signaling Regulation of GTPases through Non‐Degradative Ubiquitination

Advanced Science(2023)10.1002/advs.202303367

N/A

0DataRank · unranked

21 citations

Paolo Carai, Tonči Ivanišević, Mingzhen Zhang, Hyunbum Jang, Benoit Lechat +6 more

Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147

Biomedicines(2023)10.3390/biomedicines11072019

N/A

0DataRank · unranked

7 citations

Qi Zhang, Xiaoqing Wu, Siyuan Hao, Xinbao Hao, Elizabeth A. V. Jones +4 more

Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147

Research Square(2023)10.21203/rs.3.rs-2763207/v1

N/A

0DataRank · unranked

3 citations

Qi Zhang, Xiaoqing Wu, Siyuan Hao, Xinbao Hao, Elizabeth A. V. Jones +4 more